GlaxoSmithKline | GSK - Interest Income

Stock Price
2,193.50
Daily Change
26.50 1.22%
Monthly
20.69%
Yearly
49.57%
Q1 Forecast
2,168.74

GlaxoSmithKline reported GBP26M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
argenx SE USD 42.7M 4.3M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Fresenius Medical Care EUR 19.16M 2.69M Sep/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Merck EUR 17M 11M Jun/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Philips EUR 21M 2M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Smith & Nephew USD 15M 6M Dec/2024